Bio-Techne Statistics
Want to see TECH full AI Analyst Report?
Bio-Techne (TECH) Stock Statistics & Valuation Metrics
Total Valuation
Bio-Techne has a market cap or net worth of $11.41B. The enterprise value is $11.38B.
- Market Cap
- $11.41B
- Enterprise Value
- $11.38B
Share Statistics
Bio-Techne has 157,090,730 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 157,090,730
- Owned by Insiders
- 0.33%
- Owned by Institutions
- 94.12%
Financial Efficiency
Bio-Techne’s return on equity (ROE) is 0.09 and return on invested capital (ROIC) is 7.81%.
- Return on Equity (ROE)
- 0.09
- Return on Assets (ROA)
- 0.07
- Return on Invested Capital (ROIC)
- 7.81%
- Return on Capital Employed (ROCE)
- 0.10
- Revenue Per Employee
- 405.01K
- Profits Per Employee
- 60.62K
- Employee Count
- 3,000
- Asset Turnover
- 0.47
- Inventory Turnover
- 2.13
Valuation Ratios
The current PE Ratio of Bio-Techne is 66.08. Bio-Techne’s PEG ratio is 0.55.
- PE Ratio
- 66.08
- PS Ratio
- 9.30
- PB Ratio
- 5.26
- Price to FCF
- 37.05
- Price to Operating Cash Flow
- 33.76
- PEG Ratio
- 0.55
Income Statement
In the last 12 months, Bio-Techne had revenue of 1.22B and earned 181.86M in profits. Earnings per share was 1.17.
- Revenue
- 1.22B
- Gross Profit
- 799.07M
- Operating Income
- 251.89M
- Pretax Income
- 240.68M
- Net Income
- 181.86M
- EBITDA
- 343.44M
- Earnings Per Share (EPS)
- 1.17
Cash Flow
In the last 12 months, operating cash flow was 337.60M and capital expenditures -29.40M, giving a free cash flow of 308.20M billion.
- Operating Cash Flow
- 337.60M
- Free Cash Flow
- 308.20M
- Free Cash Flow per Share
- 1.97
Dividends & Yields
Bio-Techne pays an annual dividend of $0.08, resulting in a dividend yield of 0.55%
- Dividend Per Share
- $0.08
- Dividend Yield
- 0.55%
- Payout Ratio
- 16.49%
- Free Cash Flow Yield
- 2.70%
- Earnings Yield
- 1.51%
Stock Price Statistics
- Beta
- 0.84
- 52-Week Price Change
- 23.92%
- 50-Day Moving Average
- 72.45
- 200-Day Moving Average
- 63.06
- Relative Strength Index (RSI)
- 63.85
- Average Volume (3m)
- 2.89M
Important Dates
Bio-Techne upcoming earnings date is Feb 02, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Nov 03, 2026
- Next Earnings Date
- Feb 02, 2027
- Ex-Dividend Date
- May 18, 2026
Financial Position
Bio-Techne as a current ratio of 4.55, with Debt / Equity ratio of 13.71%
- Current Ratio
- 4.55
- Quick Ratio
- 3.35
- Debt to Market Cap
- 0.02
- Net Debt to EBITDA
- 0.07
- Interest Coverage Ratio
- 46.60
Taxes
In the past 12 months, Bio-Techne has paid 58.82M in taxes.
- Income Tax
- 58.82M
- Effective Tax Rate
- 0.24
Enterprise Valuation
Bio-Techne EV to EBITDA ratio is 34.51, with an EV/FCF ratio of 36.81.
- EV to Sales
- 9.24
- EV to EBITDA
- 34.51
- EV to Free Cash Flow
- 36.81
- EV to Operating Cash Flow
- 33.60
Balance Sheet
Bio-Techne has $351.13M in cash and marketable securities with $285.56M in debt, giving a net cash position of $65.57M billion.
- Cash & Marketable Securities
- $351.13M
- Total Debt
- $285.56M
- Net Cash
- $65.57M
- Net Cash Per Share
- $0.42
- Tangible Book Value Per Share
- $5.78
Margins
Gross margin is 65.75%, with operating margin of 19.61%, and net profit margin of 14.00%.
- Gross Margin
- 65.75%
- Operating Margin
- 19.61%
- Pretax Margin
- 18.51%
- Net Profit Margin
- 14.00%
- EBITDA Margin
- 26.77%
- EBIT Margin
- 18.89%
Analyst Forecast
The average price target for Bio-Techne is $73.00, which is 11.43% higher than the current price. The consensus rating is Moderate Sell
- Price Target
- $73.00
- Price Target Upside
- 0.51% Upside
- Analyst Consensus
- Moderate Sell
- Analyst Count
- 3
- Revenue Growth Forecast
- 0.94%
- EPS Growth Forecast
- 122.38%
Scores
- Smart Score
- 5
- AI Score
- 74

